Found 11 matching trials
Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX PHASE4 This study was undertaken to assess the immunogenicity and safety of a boos...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults PHASE1 This is a 2-Stage, Phase I/II Study to Assess the Safety, Reactogenicity, a...
Show More Location
Nucleus Network - Brisbane (Q Pharm)
Learn More & Join Trial
Post-licensure Safety Study of IMOJEVĀ® in Thailand PHASE4 The aim of this study is to further characterize the safety profile of IMOJ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEVā¢) Compared to CD.JEVAX⢠in Toddlers PHASE3 The purpose of this study is to compare Live Attenuated Japanese Encephalit...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of a Booster Dose of IMOJEVĀ® One Year After Primary Immunization in Healthy Children in South Korea PHASE3 The aim of this study was to document the immunogenicity and safety of a bo...
Show More Location
Investigational Site 004
Learn More & Join Trial
Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEVĀ®) in Healthy Subjects PHASE3 The purpose of this study is to describe the immunogenicity and safety of I...
Show More Location
Preventive Medicine Centre of Hoa Binh Province
Learn More & Join Trial
Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children PHASE4 This study has aim to describe the immune response to the second dose of Ja...
Show More Location
Department of Pediatrics, Faculty of Medicine, Khon Kaen University
Learn More & Join Trial
An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity PHASE2 We hypothesize that a high CD4+ and CD8+ T cell count will reduce viremia u...
Show More Location
SingHealth Investigational Medicine Unit
Learn More & Join Trial
Flavivirus Cross-priming Potential of IMOJEV NA There is a pressing need for a better experimental system to understand fla...
Show More Location
Liverpool University Hospitals NHS Foundation Trust
Learn More & Join Trial
Postmarketing Surveillance Study for IMOJEVĀ® in Republic of Korea N/A The purpose of the study is to perform the re-examination of IMOJEVĀ® in rou...
Show More Learn More & Join Trial